Study raises new questions about Merck pill Zetia

Courtesy Headlines from the Associated Press  Sun, 11/15/2009 - 17:16

ORLANDO, Fla. (AP) -- A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs that are still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work....


 

More related items

Study: No proof of Vytorin link to cancer
MUNICH, Germany (AP) -- New research into a possible link between a cholesterol-reducing drug and cancer concluded there was no proof to establish a connection, but other doctors warned that...

Dems Question Timing of Vytorin Papers
WASHINGTON (AP) -- House Democrats are questioning whether Merck and Schering-Plough made up information about a meeting of medical experts to discuss Vytorin, after lawmakers began...

Doctors Wary After Cholesterol Drug Flop
CHICAGO (AP) -- Full results of a failed trial on Vytorin, a medicine taken by millions of Americans to lower cholesterol, left doctors stunned that the drug did not improve heart disease...

Country Save HE Laundry Detergent, Powder, 160-Load,...

Yogi Tea Calm, Bedtime, Tea Bags, 16-Count Boxes...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com